ロード中...
Evidence‐based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney disease
Type 2 diabetes is the leading cause of chronic kidney disease (CKD). The prevalence of CKD is growing in parallel with the rising number of patients with type 2 diabetes globally. At present, the optimal approach to glycaemic control in patients with type 2 diabetes and advanced CKD (categories 4 a...
保存先:
| 出版年: | Diabetes Obes Metab |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7317405/ https://ncbi.nlm.nih.gov/pubmed/32009296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13986 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|